AI assistant
ContextVision AB Director's Dealing 2024
9979_rns_2024-11-22_10adb131-4939-4473-a131-22beb3699b3b.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Mandatory notification of trade – primary insider
Gerald Pötzsch, CEO of ContextVision, and Olof Sandén, Chairman of the Board of ContextVision has purchased shares in ContextVision.
With reference to Section 4-2 of the Norwegian Securities Trading Act ("STA"), kindly note the following primary insider share transactions:
Name of listed entity: ContextVision AB
ISIN number: SE0014731154
Stock ticker: CONTX
Name of primary insider: Olof Sandén
Relation to listed entity: Chairman of the Board
Trade: 15.000 shares Date: 08.11.2024
Average purchase price: NOK 4,83 per share
Primary insider's total shareholdings post-purchase: 18.000 shares Primary insider's percentage shareholding post-purchase: 0,002%
Name of listed entity: ContextVision AB
ISIN number: SE0014731154
Stock ticker: CONTX
Name of primary insider: Gerald Pötzsch
Relation to listed entity: CEO
Trade: 5.000 shares Date: 19.11.2024
Average purchase price: NOK 4,71 per share
Primary insider's total shareholdings post-purchase: 55.000 shares Primary insider's percentage shareholding post-purchase: 0,07%
Name of listed entity: ContextVision AB
ISIN number: SE0014731154
Stock ticker: CONTX
Name of primary insider: Gerald Pötzsch
Relation to listed entity: CEO
Trade: 15.000 shares Date: 25.09.2024
Average purchase price: NOK 5,26 per share
For more information, please contact:
About ContextVision
ContextVision is a medical technology software company specialized in image analysis and artificial intelligence. As the global market leader within image enhancement, we are a trusted partner to leading manufacturers of ultrasound, X-ray and MRI equipment around the world. Our expertise is to develop powerful software products, based on proprietary technology and artificial intelligence for image-based applications. Our cutting-edge technology helps clinicians accurately interpret medical images, a crucial foundation for better diagnosis and treatment. The company, established in 1983, is based in Sweden with local representation in the U.S., Japan, China and Korea. ContextVision is listed on the Oslo Stock Exchange under the ticker CONTX.